Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…[Me₂NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me₂NN]Cu}₂(μ-η²:η¹-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η² and η¹ bonding of the ArNO moiety with separate [Me₂NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…[Me₂NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me₂NN]Cu}₂(μ-η²:η¹-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η² and η¹ bonding of the ArNO moiety with separate [Me₂NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…[Me₂NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me₂NN]Cu}₂(μ-η²:η¹-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η² and η¹ bonding of the ArNO moiety with separate [Me₂NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”

Nitric Oxide Oxidatively Nitrosylates Ni(I) and Cu(I) <i>C</i>-Organonitroso Adducts by Stefan Wiese (1626535)

“…[Me₂NN]Cu(NCMe) reacts with 0.5 equiv of ArNO in ether to give the dinuclear adducts {[Me₂NN]Cu}₂(μ-η²:η¹-ONAr) (<b>2a</b> and <b>2b</b>), which exhibit η² and η¹ bonding of the ArNO moiety with separate [Me₂NN]Cu fragments possessing N−O distances of 1.375(6) Å (<b>2a</b>) and 1.368(2) Å (<b>2b</b>). …”

Enforced miR-509 expression in decreased proportion of cells in S-phase, induced apoptosis and activated caspase-3/7. by Yee Sun Tan (176098)

Decrease in total RNA after enzymes treatment in culture supernatant samples. by Gilberto Gutiérrez García (9611388)

Incorporating a social responsibility goal in the prompt causes overleverage in utilities (A) and decreases risk of low ESG rating (B) (Study 3). by Philipp Winder (21615570)

Diabetic <i>TauT</i>-deficient mice showed kidney hypertrophy and decreased survival rate. by Xiaobin Han (608327)

Distinct effects on calcium channel activation of <i>CACNA1I</i> disease-associated amino acid substitutions A398E/V and M1425V/I. by Yousra El Ghaleb (22075892)

Subjects:

Increased AHP Amplitude and decreased AP firing in the presence of kainic acid is dependent on the GluR5 subunit. by Barbara Gisabella (330774)

Fig 5 - by Melissa A. Hill (13170105)

Mice exposed to neonatal hyperoxia have persistent RVH and decreased vessel density at 21d. by Marta Perez (526067)

Mood and reward. by Vasileios Mantas (16949352)

Metformin pre-administration decreases the oxidative stress, retains antioxidant effect and decreases apoptosis in colon and lung tissues in mice irradiated with GCRsim. by Silvia Siteni (10344070)

Decreases in CAPs. by Enrico Amico (527269)

“…<p>This figure shows the local decreases in co-activation from wakefulness to unconsciousness, using the same t-contrast as in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0100012#pone.0100012-Boveroux1" target="_blank">[7]</a>. …”

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on bacterial load after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on inflammatory mediators after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage. by Jin Zhou (90734)

ASV and supplemental oxygen sleep treatments decrease fatigue and confusion. by Erica C. Heinrich (6832055)

Phenethyl isothiocyanate activates leptin signaling and decreases food intake by Miho Yagi (5921252)

“…Leptin is a weight-reducing hormone produced by adipose tissue, which decreases food intake <i>via</i> hypothalamic leptin receptors (Ob-Rb) and the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway. …”